Share This Author
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.
Body Mass Index and the Risk for Crohn's Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The IBD in EPIC Study)
Obesity as measured by BMI is not associated with the development of incident UC or CD, and alternative measures of obesity are required to further investigate the role of obesity in theDevelopment of incident IBD.
High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study.
This study found no statistically significant beneficial effect of a higher dose of ursodeoxycholic acid than previously used on survival, symptoms, biochemistry, and quality of life in primary sclerosing cholangitis.
The natural history of small-duct primary sclerosing cholangitis.
Small-duct PSC is a disease of progressive potential but associated with a better long-term prognosis as compared with large-ductPSC, and cholangiocarcinoma does not seem to occur in patients with small- duct PSC, unless the disease has progressed to large- abduct PSC.
Acute liver failure in Sweden: etiology and outcome
- G. Wei, A. Bergquist, E. Björnsson
- Medicine, Political ScienceJournal of internal medicine
- 1 September 2007
Objective. To determine the causes and outcome of all patients with acute liver failure (ALF) in Sweden 1994–2003 and study the diagnostic accuracy of King's College Hospital (KCH) criteria and the…
Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis
- S. Lindgren, L. Flood, A. Kilander, R. Löfberg, T. Persson, R. Sjödahl
- MedicineEuropean journal of gastroenterology & hepatology
- 1 October 1998
Sustained elevation of body temperature, persistent bloody diarrhoea and continued CRP elevation on day 3 of intravenous GCS treatment strongly predict clinical steroid resistance in acute attacks of ulcerative colitis.
Prevalence of Anemia in Inflammatory Bowel Diseases in European Countries: A Systematic Review and Individual Patient Data Meta-analysis
The overall prevalence of anemia in patients with Crohn's disease was 27% and 21% (95% confidence interval, 15–27) in Patients with ulcerative colitis, and 57% of the anemic patients were iron deficient.
High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis.
Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case–control study within a European prospective cohort study
A role for dietary linoleic acid in the aetiology of ulcerative colitis is supported, with an estimated 30% of cases could be attributed to having dietary intakes higher than the lowest quartile of linolesic acid intake.
Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study
Treatment with intravenous iron sucrose is effective, safe, well tolerated and superior to oral iron in correcting haemoglobin and iron stores in patients with IBD.